We observed a higher proportion of breast cancer cases younger than 50 years in families with pathogenic mutations in BRCA1, while most patients the BRCA1-VUS and BRCA1-WT groups reported only one or two cases diagnosed before the age of 50 (p = 0.005). The gene discussed is BRCA1; the disease is breast carcinoma.